Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent (Q37340510)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2003
edit
Language Label Description Also known as
English
Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent
scientific article published on June 2003

    Statements

    Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent (English)
    M B Jameson
    P I Thompson
    B C Baguley
    B D Evans
    V J Harvey
    D J Porter
    M R McCrystal
    M Small
    K Bellenger
    L Gumbrell
    G W Halbert
    P Kestell
    Phase I/II Trials Committee of Cancer Research UK
    1 June 2003
    1844-1850

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit